Suchergebnisse - "Pacheco, Paulo A F"

PubPharm (9)

1

Are Purinergic Receptors Overlooked Targets in Hyperinflammatory Responses?

enthalten in: Current molecular pharmacology | 2024

von Pacheco, P. | Faria, R.

2

Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis

enthalten in: Molecules (Basel, Switzerland) | 2022

von Pacheco, P. | Santos, M.

3

The potential involvement of P2X7 receptor in COVID-19 pathogenesis : A new therapeutic target?

enthalten in: Scandinavian journal of immunology | 2021

von Pacheco, P. | Faria, R.

4

Juglone : A Versatile Natural Platform for Obtaining New Bioactive Compounds

enthalten in: Current topics in medicinal chemistry | 2021

von Dos S Moreira, C. | Santos, T. | Freitas, R. | +2

5

Juglone: A Versatile Natural Platform for Obtaining New Bioactive Compounds

enthalten in: Current topics in medicinal chemistry | 2021

von dos S. Moreira, C. | Santos, T. | Freitas, R. | +2

6

The potential involvement of P2X7 receptor in COVID‐19 pathogenesis : A new therapeutic target?

enthalten in: Scandinavian Journal of Immunology | 2021

von Pacheco, P. | Faria, R.

7

Putative roles of purinergic signaling in human immunodeficiency virus-1 infection

enthalten in: Biology direct | 2014

von Pacheco, P. | Faria, R. | Ferreira, L. | +1

8

Enhanced Th17 phenotype in individuals with generalized anxiety disorder

enthalten in: Journal of neuroimmunology | 2010

von Vieira, M. | Ferreira, T. | Pacheco, P. | +9

9

Enhanced Th17 phenotype in individuals with generalized anxiety disorder

enthalten in: Journal of neuroimmunology | 2010

von Vieira, M. | Ferreira, T. | Pacheco, P. | +9

1
[1]